Clarification of entry criteria for the European Organization for Research and Treatment of Cancer H5-favorable trial of early-stage Hodgkin's disease
- PMID: 8080569
- DOI: 10.1200/JCO.1994.12.8.1739
Clarification of entry criteria for the European Organization for Research and Treatment of Cancer H5-favorable trial of early-stage Hodgkin's disease
Comment on
-
Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.J Clin Oncol. 1988 Feb;6(2):239-52. doi: 10.1200/JCO.1988.6.2.239. J Clin Oncol. 1988. PMID: 2578012 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
